Bio-Works Technologies AB Statistics

Total Valuation

NGM:BIOWKS has a market cap or net worth of SEK 106.03 million. The enterprise value is 71.75 million.

Market Cap	106.03M
Enterprise Value	71.75M

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

NGM:BIOWKS has 77.96 million shares outstanding. The number of shares has increased by 38.31% in one year.

Current Share Class	n/a
Shares Outstanding	77.96M
Shares Change (YoY)	+38.31%
Shares Change (QoQ)	+78.64%
Owned by Insiders (%)	24.17%
Owned by Institutions (%)	13.11%
Float	39.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.48
PB Ratio	2.38
P/TBV Ratio	2.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.92
EV / Sales	2.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.66

Financial Position

The company has a current ratio of 6.41

Current Ratio	6.41
Quick Ratio	4.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,977.22

Financial Efficiency

Return on equity (ROE) is -84.31% and return on invested capital (ROIC) is -50.49%.

Return on Equity (ROE)	-84.31%
Return on Assets (ROA)	-39.03%
Return on Invested Capital (ROIC)	-50.49%
Return on Capital Employed (ROCE)	-80.28%
Revenue Per Employee	1.02M
Profits Per Employee	-1.25M
Employee Count	30
Asset Turnover	0.53
Inventory Turnover	0.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.41% in the last 52 weeks. The beta is 1.17, so NGM:BIOWKS's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-66.41%
50-Day Moving Average	1.36
200-Day Moving Average	1.29
Relative Strength Index (RSI)	53.12
Average Volume (20 Days)	87,742

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:BIOWKS had revenue of SEK 30.49 million and -37.36 million in losses. Loss per share was -0.75.

Revenue	30.49M
Gross Profit	25.04M
Operating Income	-35.80M
Pretax Income	-37.28M
Net Income	-37.36M
EBITDA	-35.28M
EBIT	-35.80M
Loss Per Share	-0.75

Full Income Statement

Balance Sheet

The company has 34.28 million in cash and n/a in debt, giving a net cash position of 34.28 million or 0.44 per share.

Cash & Cash Equivalents	34.28M
Total Debt	n/a
Net Cash	34.28M
Net Cash Per Share	0.44
Equity (Book Value)	44.58M
Book Value Per Share	0.57
Working Capital	42.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -43.17 million and capital expenditures -8,000, giving a free cash flow of -43.18 million.

Operating Cash Flow	-43.17M
Capital Expenditures	-8,000
Free Cash Flow	-43.18M
FCF Per Share	-0.55

Full Cash Flow Statement

Margins

Gross margin is 82.13%, with operating and profit margins of -117.41% and -122.54%.

Gross Margin	82.13%
Operating Margin	-117.41%
Pretax Margin	-122.29%
Profit Margin	-122.54%
EBITDA Margin	-115.73%
EBIT Margin	-117.41%
FCF Margin	n/a

Dividends & Yields

NGM:BIOWKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.31%
Shareholder Yield	-38.31%
Earnings Yield	-35.23%
FCF Yield	-40.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:BIOWKS has an Altman Z-Score of -1.33. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.33
Piotroski F-Score	n/a